~~<i id='B53FC1038E'><strike id='B53FC1038E'><tt id='B53FC1038E'><pre id='B53FC1038E'></pre></tt></strike></i>~~

Home» explore» entertainment

entertainment

author：knowledge 2025-09-28 18:42:27 Page View：8

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： H5N1 communication has been strictly for the birds
Next article： New air purifier tech could be key to improving indoor air quality

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Telehealth startups turn to complex chronic diseases

MollyFergusonforSTATIfherneurologistmovedtoChina,LaurenStilessaysshe’dfollowhimthere.“There’ssofewdo

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

Emergency workers more likely to restrain Black patients: study

MishaFriedman/GettyImagesInthechaoticenvironmentofanemergencyroom,hospitalstafferssometimesfacethequ